ARTICLE | Clinical News

GBR 830: Phase I data

September 14, 2015 7:00 AM UTC

Data from Dutch Phase I trials in healthy volunteers showed that GBR 830 was well tolerated. In the next few months, Glenmark plans to start Phase II testing of GBR 830 to treat atopic dermatitis and ...